Background: 

Labral reconstruction has been shown to result in improved patient-reported outcomes (PROs) at mid-term follow-up in patients with a deficient labrum. The purpose of this study was to determine survivorship and PROs at a minimum 10-year follow-up.

Methods: 

A retrospective evaluation of a prospectively collected single-surgeon database included 91 hips (89 patients) that underwent arthroscopic labral reconstruction with iliotibial band autograft between 2006 and 2008. The primary PRO was the Hip Outcome Score (HOS)-activities of daily living (ADL). The modified Harris hip score (mHHS), HOS-sports, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score, and patient satisfaction (on a scale of 1 to 10) were also collected at a 10-year minimum follow-up. Survivorship analysis curves were evaluated.

Results: 

Eighty-two hips were evaluated at a 10-year minimum follow-up. Overall survivorship, with revision hip arthroscopy or total hip arthroplasty (THA) as the end point, was 70% at 5 years and 61% at 10 years, and the mean survival time was 9 years (95% confidence interval = 7.6 to 10 years). For the patients who did not undergo subsequent surgery, on average the mHHS increased from 60 preoperatively to 82 at the 10-year follow-up (p = 0.001), the HOS-ADL improved from 69 to 90 (p = 0.004), the HOS-sports improved from 43 to 76 (p = 0.001), and the median patient satisfaction was 10 of 10. Eighty percent of the patients achieved the minimal clinically important difference (MCID) in the HOS-ADL, and 87% obtained a patient acceptable symptom state (PASS).

Conclusions: 

Following arthroscopic labral reconstruction with iliotibial band autograft, 9% of the hips underwent revision arthroscopy and 27% underwent THA. At 10 years, the survival rate, with revision hip arthroscopy or THA as the end point, was 61%; however, for those with >2 mm of joint space, the current indication for labral reconstruction, the 10-year survival rate was 90%. Excellent PROs and patient satisfaction were reported by those who did not require revision or THA. With appropriate patient selection and prevention of postoperative adhesions, labral reconstruction results in excellent outcomes and high patient satisfaction that is sustained at a minimum 10-year follow-up.

Level of Evidence: 

Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

中文翻译：

---

I胫束自体移植髋臼复健：至少10年的随访结果和生存率。

背景： 

阴唇重建患者的中期随访结果显示，阴唇重建可以改善患者报告的结局（PROs）。这项研究的目的是在至少10年的随访中确定存活率和PRO。

方法： 

回顾性评估了一个前瞻性收集的外科医生数据库，其中包括91例髋关节（89例患者），这些髋关节在2006年至2008年之间接受了胫束带自体移植进行关节镜下人工唇重建。 ）。在至少10年的最小随访中，还收集了改良的Harris髋关节评分（mHHS），HOS运动，西安大略省和麦克马斯特大学骨关节炎指数（WOMAC）评分以及患者满意度（1到10分）。评估生存分析曲线。

结果： 

在最少十年的随访中评估了八十二只臀部。以翻修髋关节镜或全髋关节置换术（THA）为终点的总体生存率为5年时为70％，10年时为61％，平均生存时间为9年（95％置信区间= 7.6至10年）。对于未进行后续手术的患者，在10年的随访中，平均mHHS从术前60增至82（p = 0.001），HOS-ADL从69增至90（p = 0.004）， HOS运动从43改善为76（p = 0.001），中位患者满意度为10的10。80％的患者实现了HOS-ADL的最小临床重要差异（MCID），87％的患者获得了可接受的症状状态（PASS）。

结论： 

在用oti胫束带自体移植关节镜进行人工阴唇重建之后，9％的髋关节接受了翻修关节镜，27％的髋关节接受了THA。10年时，以翻修髋关节镜或THA为终点的生存率为61％。然而，对于那些关节间隙> 2 mm的患者，当前的阴唇再造指征为10年生存率为90％。不需要修订或THA的患者报告了出色的PRO和患者满意度。通过适当的患者选择和术后粘连的预防，进行至少10年的随访，可以改善唇唇重建的效果，并获得很高的患者满意度。

证据级别： 

治疗级别IV。有关证据水平的完整说明，请参见《作者说明》。